MicrobiologybioRxiv
A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells
M. Mahoney, V. C. Damalanka, M. Tartell…·J. W. Janetka
This paper identifies a novel class of TMPRSS2 inhibitors that effectively block SARS-CoV-2 and MERS-CoV entry and show promise as a therapeutic for COVID-19.
DOI 10.1073/pnas.2108728118